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1033-94 Calclneurln Inhibition Does Not Prevent Left Ventricular 
Hypertrophy but Does Suppress Its Molecular Markers 
in a Rat Model of Low-Renin, Mild Pressure Overload 
Aislino C. McMahon. Victoria L. Benson, Scott H. Kesteven, Michael P. Feneley, St 
Vincent's Hospital, Sydney, Australia, Victor Chang Cardiac Research Institute, Sydney, 
Australia. 
Background: The role of the Ca 2+ dependent calcineurin (Cn) signalling pathway in the 
pathogenesis of pressure overload left ventdcular hypertrophy (LVH) is controversial. 
The aim of this study was to investigate the relationship between the Cn pathway and the 
development of LVH in a rat model of Iow-renin, mild pressure overload. 
Methods: Male Wistar rats were randomly assigned to receive either 1 mg/kg FK506 
daily IP (FK) or an equivalent volume of saline, IP (S). After 3d, half of each group was 
then subjected to banding of the aortic arch (B). The remaining animals were sham-oper- 
ated controls (C). LV / body weight ratios (LV / BWt) and molecular markers of hypertro- 
phy were studied 7 and 21d after surgery. Relative expression (normalised to the saline- 
control [SC] group) of ANF, ~-skeletal actin and BNP in LV tissue samples was assessed 
by RT-PCR. 
Reeults: At 7d, there was no increase in LV / BWt in SB animals compared with SC. 
Consistent with this finding, there was no change in the expression of the molecular 
markers examined. In contrast, after 21d an increase in LV / BWt of 13±8% (p<0.005) 
was found in SB; but there was no difference between SB and FKB in the degree of LVH 
induced (0.0023±0.0002 vs 0.0023±0.0003; n.s.). Peak aortic pressure gradients were 
similar in SB and FKB at 21d (35±15, n=10 vs 33±16 mmHg, n=9 respectively) and band- 
ing per se did not cause an increase in plasma renin activity. The RT-PCR data (n=5-6 
per group) at 21d indicated a 4-fold increase in ANF expression (p<0.03), a lO-fold 
increase in (:(-skeletal actin expression (p<0.04) and a 9-fold increase in BNP expression 
(p<0.06; n,s.) in SB compared with SC animals; no change in the expression levels of 
these markers was observed in FKB animals. 
Conclusions: 1. FK506 does not prevent pressure overload hypertrophy in this model, 
suggesting that the Cn pathway per se is not critical for the development of LVH, when 
renin is not elevated. 2. The supression of molecular markers associated with LVH with- 
out supression of LVH in FKB indicates that these proteins are causally related to the Cn 
cascade but not necessary for the genesis of LVH. 3. Collectively, these data suggest 
that alternative intracellular signalling pathways are responsible for LVH in this model. 
1033-95 Stimulation of Arechidonic Acid Release From Mas- 
Transfected COS Cells Is Not Restricted to Angiotensin- 
(1-7) and Does Not Involve AT1 and AT2 Receptors 
Insa de Buhr, Martin Vahl, Thomas Walther, Department of Cardiology and Pneumo/ogy, 
Free University of Berlin, Berlin, Germany, 
Background: Besides angiotensin (Ang) II, other Ang peptides, as Ang III (Ang-(2-8)), 
Ang IV (Ang-(3-8)), and Ang-(1-7) also have biological activities. Especially Ang-(1-7) 
has become an angiotensin of interest, since its vascular and baroreflex actions counter- 
act those of Ang IL Recently, it could be demonstrated that Ang-(1-7) is a functional 
ligand of the G protein-coupled receptor Mas. We wanted to examine whether other Ang 
receptors are involved in the ligand/receptor interaction and if other Ang metabolites also 
affect the signalling pathway of Mas. 
Methods: COS cells were transfscted with a pcDNA-Mas construct (Mas-transfected 
cells). COS cells, transfected only with the plasmid pcDNA, served as control cells. Cells 
were incubated with (SH)arachidonic acid (AA) for 18h. 15 rain after adding the angio- 
tensins and their antagonists, the amount of (3H)AA release was measured by liquid scin- 
tigraphy. To evaluate the spscifity of Ang-(1-7) binding, we used, beside the specific Ang- 
(1-7) antagonist A-779, antagonists for the angiotensin receptors AT1 (Irbesartan) and 
AT2 (PD123319). 
Results: Control cells were found to react on incubation with 10-8 M Ang-(1-7), Ang III, or 
Ang IV with a slight increase in pH)AA release (35%±9%, 14%±4%, 12%±5%;n=8). The 
incubation of Mas-transfected COS cells with Ang-(1-7) resulted in 265%¢45% (n=8) 
increased (3H)AA release compared to control cells. Ang III and IV elevated the amount 
of pH)AA release by 111%±26% and f f 2%±23% (n=4), whereas incubation with Ang I 
and Ang I1 showed no changes. The (3H)AA release induced by Ang-(1-7) was totally 
blocked by A-779 but preserved by PD123319 and Irbesartan. 
Conclusion: Ang-(1-7) stimulates the AA pathway specifically via the Mas receptor. Ang 
Ill and Ang IV also stimulate AA release from Mas-transfected cells. In contrast, Ang I 
and Ang II have not been effective. The fact that A-779 blocks (3H)AA release suggests 
A-779 to be a specific antagonist of the Mas receptor. Neither AT1 nor AT2 receptors are 
involved in the interaction between Ang-(1-7) and Mas. These findings could open new 
goals in cardiovascular therapy by pharmacological manipulation at the Mas receptor. 
1033-96 Characterization of a Novel Inositol 1,4,5-Trisphosphate 
Receptor/Calclneurln Signaling Pathway in Cardiac 
Hypertrophy: Effects of Heparin 
Zhimino Zhu. Shanjun Zhu, Yongjian Yang, Department of Hypertension and 
Endocrinology, Chongqing Institute of Hypertension, Daping Hospital, Chongqing, 
People's Republic of China. 
Background: Cardiac hypertrophy may be regulated primarily by hypertrophy-stimulating 
factors. However, little is known about the cardiac growth-inhibitory factors that nega- 
tively regulate the formation of cardiac hypertrophy. Recently, a calcium-dependent cal- 
cineudn (CN) / nuclear factor of activated T-lymphocytes-3 (NFAT3) / GATA4 signaling 
pathway was found to be involved in cardiac hypertrophy. Heparin has been shown to 
prevent growth and proliferation of cardiomyocytes besides its well-characterized antico- 
agulant action. Heparin specifically inhibits the 1,4,5-trisphosphate receptor (InsP3R) 
which is an intracellular calcium release channel. We postulated that activation of InsP3R 
mediated CN / NFAT3 / GATA4 pathway have a potential role in regulation of cardiomyo- 
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cyte hypertrophy and heparin may antagonize this signaling pathway. Methods and 
Results: primary neonatal rat cardiomyocytes were cultured using established tech- 
niques. Fluorescenee-spectrophotometric measurements using fura2 showed that InsP3 
caused a dose-dependent increase of cytostolic free calcium concentration in cardiomyo- 
cytes ( IP3 100 nmol: 138±7 vs 223±8 nmol/I, p<0.01). InsP3 increased 3H-thymidine 
(IP3 100 nmol: 35637±175 vs 138106±2494 cpm/well, P<O.0t) and 3H-leucine ( IP3 100 
nmol: 838±19 vs 1534±119 cpm/well, p<0.01) incorporation in a time- and dose-depen- 
dent manner. Immunoblotting showed that InsP3 significantly enhanced the expression 
of c-los, c-myc, alpha-actin and beta-MHC in cardiomyocytes. Administration of InsP3 
time-dependently increased the expression of CN, NFAT3 and GATA4. The InsP3- 
induced CN expression was blocked by heparin administration. Conclusions: The study 
indicates that the InsP3 sensitive calcium pool is related to cardiac hypertrophic gene 
regulatory pathways. Antagonizing the InsP3R/CN/NFAT3/GATA4 signaling pathway 
may be a new therapeutic target for cardiac hypertrophy. (Supported by grant from NSFC 
No. 39725013). 
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1034-69 Lysophoephatidylcholine Is a Major Contributor to the 
Synergistic Effect of Mildly Oxidized Low-Density 
Lipoproteln With Endothelin-1 on Vascular Smooth 
Muscle Cell Proliferation 
Takuva Watanabe, Takashi Katagid, Rajbabu Pakala, Claude R. Benedict, Third 
Department of Intemal Medicine, Showa University School of Medicine, Tokyo, Japan, 
Division of Cardiology, University of Texas-Houston Health Science Center, Houston, 
Texas. 
Background: Endothelin-1 (ET-1) and oxidatively modified low-density lipoprotein (LDL) 
are associated with essential hypertension and atherosclerosis. We assessed the effect 
of mildly oxidized LDL (mox-LDL) and highly oxidized LDL (ox-LDL) and their major oxi- 
dative components, i.e., reactive oxygen species (ROS), lysophosphetidylcholine (LPC), 
and 4-hydroxy-2-nonenal (HNE) and their interaction with ET-1 on VSMC proliferation. 
Methods: Growth-arrested VSMCs isolated from the rabbit aorta were incubated with dif- 
ferent concentrations of native LDL, mox-LDL, ox-LDL, hydrogen peroxide (a donor of 
ROS), LPC, or HNE with or without ET-1. DNA synthesis in VSMCs was measured by 
[3H]thymidine incorporation. 
Results: Mox-LDL, ox-LDL, hydrogen peroxide, LPC, HNE, or ET-1 stimulated DNA syn- 
thesis in a dose-dependent manner. Maximal effect was observed at 5 microg/ml for 
mox-LDL (162%) or ox-LDL (154%), 15 microM LPC (156%), 5 microM hydrogen perox- 
ide (177%), 1 microM HNE (144%), and 0.1 microM ET-1 (195%). By contrast, native 
LDL was without any significant effect. When added together, there was no synergistic 
effect of native LDL, hydrogen peroxide, or HNE with ET-1 on DNA synthesis. However, 
the effect of mox-LDL (0.1 microg/ml), ox-LDL (0.5 microg/ml), or LPC (10 microM) was 
potentiated by ET-1 (114 to 338%, 133 to 425%, 118 to 333%, respectively). The mitoge- 
nic effect of mox-LDL, ox-LDL, or LPC and their interaction with ET-1 were inhibited by 
defatted albumin (10 microg/ml), antioxidant N-acetylcysteine (400 microM), the NADPH 
oxidase inhibitor diphenylene iodonium (1 microM). The mitogenic effect of ET-1 and its 
interaction with mox-LDL, ox-LDL, or LPC were inhibited by the ETNB receptor antago- 
nist TAK044 (1 microM) or the MAPK kinase inhibitor PD098059 (10 microM). The syner- 
gistic interaction of moxoLDL, ox-LDL, or LPC with ET-1 was completely reversed by the 
combined use of N-acetylcysteine and TAK044. 
Conclusions: Our results suggest that mox-LDL, ox-LDL, and their major phospholipid 
component LPC act synergistically with ET-1 in inducing VSMC proliferation via the acti- 
vation of redox-sensitive and MAPK pathways. 
1034-71 Chronic Reduction of Carotid Blood Flow Causes Salt- 
Sensitive Hypertension in Rats 
Masato Nishimura, Hiroyuki Kobayashi, Tetsuya Hashimoto, Toyoshi Fukuda, Koji Okino, 
Nodyuki Yamamoto, Toshikazu Yoshikawa, Toshihiko Ono, Toujinkai hospital, Kyoto, 
Japan, Kyoto Prefectural University of Medicine, Kyoto, Japan. 
Background: Obstruction of extracranial carotid artery is reportedly associated with sys- 
tolic hypertension in adults. We asked in the ,present study whether chronic reduction of 
carotid blood flow elicits salt-sensitive hypertension through regulation of the renin-angio- 
tensin system (RAS) in the brain. 
Methods: Bilateral internal carotid arteries of 12-week-old male Wistar rats (n = 40) were 
ligated at one-week interval. Carotid-ligated or sham-operatad rats were treated with high 
salt (8% NaCI diet and 1% NaCI drinking water) or low salt (0.3% NaCI diet and distilled 
water) for 6 weeks. Systolic arterial pressure (SAP) was measured using ts:ll-cuff 
method, and diurnal urinary excretion of arginine vasoprassin and norepinephrine was 
measured once a week. At the end of the experiment, expression of the RAS messenger 
FINAs in the hypothalamus and lower brainstem was measured using competitive RT- 
PCR method. Effects of a 6-day intracerebroventricular infusion of CV-11974 (10 mg/kg/ 
d, n = 8, 80 mg/kg/d, n = 8), a blocker of angiotensin II type-1 receptor, or vehicle (artifi- 
cial cerabrospinal fluid, n = 8) on SAP, heart rate, urinary excretion of vasopressin and 
norapinephrine were investigated in carotid-ligated rats administered with high-salt for 6 
weeks. 
